Group 1 - Wuhan Yifei Laser Co., Ltd. has obtained a patent for "AGV Automatic Docking Buffer Conveyor Line," with the authorization announcement number CN222906678U, applied on April 2024 [1] - The patent describes a system that includes AGV carts, a base, a receiving mechanism, a buffering mechanism, and a transfer mechanism, designed to enhance the efficiency of material supply in battery production [1] - The AGV automatic docking buffer conveyor line can automatically transport pallets delivered by AGV carts to the supply point, increasing supply efficiency and reducing waiting time [1] Group 2 - Wuhan Yifei Laser Co., Ltd. was established in 2005 and is primarily engaged in the manufacturing of specialized equipment, with a registered capital of 95.162608 million RMB [2] - The company has invested in 10 enterprises and participated in 65 bidding projects, holding 26 trademark records and 617 patent records [2] - Additionally, the company possesses 11 administrative licenses [2]

北京德恒（杭州）律师事务所 关于 武汉逸飞激光股份有限公司 法律意见书 杭州市上城区新业路 200 号华峰国际商务大厦 10-11 楼 电话：0571-86508080 传真：0571-87357755 邮编：310016 北京德恒（杭州）律师事务所 关于武汉逸飞激光股份有限公司 北京德恒（杭州）律师事务所 关于武汉逸飞激光股份有限公司 法律意见书 德恒【杭】书（2025）第05075号 致：武汉逸飞激光股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）《中华人民 共和国公司法》（以下简称"《公司法》"）和中国证券监督管理委员会关于 《上市公司股东会规则》（以下简称"《股东会规则》"）等法律、法规和其 他有关规范性文件的要求，北京德恒（杭州）律师事务所（以下简称"本所"） 接受武汉逸飞激光股份有限公司（以下简称"逸飞激光"或"公司"）的委托， 指派律师参加逸飞激光 2024 年年度股东大会（以下简称"本次股东大会"）， 并出具《北京德恒（杭州）律师事务所关于武汉逸飞激光股份有限公司 2024 年 年度股东大会的法律意见书》（以下简称"本《法律意见书》"）。 本《法律意见书》仅供逸飞激光 20 ...

| 审议结果：通过 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 表决情况： | | | | | | | | | | | | 同意 | | 反对 | | | 弃权 | | | | | 股东类型 | | | | 比例 | | 比例 | | | | | 票数 | | 比例（%） | | 票数 | | 票数 | | | | | | | | | （%） | | （%） | | | | | 普通股 | 40,793,562 | 99.3427 | 181,212 | 0.4412 | 88,692 | 0.2161 | | | | | 审议结果：通过 | | | | | | | | | | | 表决情况： | | | | | | | | | | | | 同意 | | 反对 | | | 弃权 | | | | | 股东类型 | | | | 比例 | | 比例 | | | | | 票数 | | 比例（%） | | 票数 | | 票数 | | | | | | | | | （%） | | （%） | | | ...

本次会议是否有被否决议案：无 一、 会议召开和出席情况 证券代码：688646 证券简称：ST 逸飞 公告编号：2025-041 武汉逸飞激光股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （一） 股东大会召开的时间：2025 年 05 月 22 日 （二） 股东大会召开的地点：湖北省鄂州市葛店开发区高新四路逸飞激光行政 楼 4 楼会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 83 | | --- | --- | | 普通股股东人数 | 83 | | 2、出席会议的股东所持有的表决权数量 | 41,063,466 | | 普通股股东所持有表决权数量 | 41,063,466 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 45.6683 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 45.6683 | ...

北京德恒（杭州）律师事务所 关于 武汉逸飞激光股份有限公司 2024 年年度股东大会的 法律意见书 杭州市上城区新业路 200 号华峰国际商务大厦 10-11 楼 电话：0571-86508080 传真：0571-87357755 邮编：310016 北京德恒（杭州）律师事务所 关于武汉逸飞激光股份有限公司 2024 年年度股东大会的法律意见书 北京德恒（杭州）律师事务所 本《法律意见书》仅供逸飞激光 2024 年年度股东大会之目的使用。本所律 师同意将本《法律意见书》随逸飞激光本次股东大会其他信息披露资料一并公 告。 本所律师根据《股东会规则》第六条的要求，按照律师行业公认的业务标 准、道德规范和勤勉尽责的精神，对逸飞激光本次股东大会所涉及的有关事项 和相关文件进行了必要的核查和验证，出席了逸飞激光 2024 年年度股东大会， 现出具法律意见如下： 2025 年 4 月 28 日，公司召开第二届董事会第十三次会议，作出召开本次股 东大会的决议，本次股东大会的召集人是公司董事会。 关于武汉逸飞激光股份有限公司 2024年年度股东大会的 法律意见书 一、本次股东大会召集、召开的程序 德恒【杭】书（2025）第0 ...

武汉逸飞激光股份有限公司 2024 年年度股东大会会议资料 证券代码：688646 证券简称：逸飞激光 武汉逸飞激光股份有限公司 会议资料 目 录 武汉逸飞激光股份有限公司 2024 年年度股东大会会议资料 议案八：关于预计 2025 年度公司及子公司申请综合授信额度并提供担保的 武汉逸飞激光股份有限公司 2024 年年度股东大会会议资料 武汉逸飞激光股份有限公司 为维护广大投资者的合法权益，保障股东在本次股东大会期间依法行使权利， 根据《公司法》、中国证监会《上市公司股东会规则》和公司《股东大会议事规 则》等有关规定，武汉逸飞激光股份有限公司（以下简称"公司"）特制定本会 议须知： 一、公司负责本次股东大会的议程安排和会务工作，为确认出席大会的股东 或其代理人或其他出席者的出席资格，会议工作人员将对出席会议者的身份进行 必要的核对工作，请被核对者给予配合。 二、出席会议的股东及股东代理人须在会议召开前半小时到会议现场办理签 到手续，并按规定出示证券账户卡等持股证明、身份证明文件或营业执照/注册 证书复印件（加盖公章）、授权委托书等，上述登记材料均需提供复印件一份， 个人登记材料复印件须个人签字，法定代表人证 ...

武汉逸飞激光股份有限公司 2024 年年度股东大会会议资料 证券代码：688646 证券简称：逸飞激光 武汉逸飞激光股份有限公司 2024 年年度股东大会 会议资料 2025 年 5 月 武汉逸飞激光股份有限公司 2024 年年度股东大会会议资料 | | | | 2024 | 年年度股东大会会议须知 1 | | --- | --- | | 2024 | 年年度股东大会会议议程 3 | | 2024 | 年年度股东大会会议议案 5 | | 议案一：关于 | 2024 年度董事会工作报告的议案 5 | | 议案二：关于 | 2024 年度独立董事述职报告的议案 6 | | 议案三：关于 | 2024 年度监事会工作报告的议案 7 | | 议案四：关于 | 2024 年度财务决算报告的议案 8 | | 议案五：关于 | 2024 年年度报告及其摘要的议案 9 | | 议案六：关于 | 2024 年度利润分配方案的议案 10 | | | 议案七：关于续聘 2025 年度会计师事务所的议案 11 | | | 议案八：关于预计 2025 年度公司及子公司申请综合授信额度并提供担保的 | | 议案 | 12 | | | 议 ...

Group 1 - The People's Bank of China has established a stock repurchase and increase loan tool, leading to a significant rise in listed companies' repurchase activities, with a total proposed loan amount exceeding 110 billion yuan by April 2025 [1] - On May 7, 2023, the People's Bank of China announced a combined usage of 500 billion yuan for securities, funds, and insurance company swaps, along with 300 billion yuan for stock repurchase loans, totaling 800 billion yuan, while also reducing the interest rate on structural monetary policy tools by 0.25 percentage points to 1.5% [1] - Industry insiders expect a resurgence in stock repurchase activities among listed companies in the near future [1] Group 2 - In January 2023, 60 listed companies conducted stock repurchases, followed by 48 in February, 61 in March, 54 in April, and 34 so far in May [3] - Palin Bio led the increase in repurchase activities with 55 instances, totaling 187,800 shares and an investment of 3.96 million yuan [3] - Other notable companies include Jerry Shares with 25 repurchase instances totaling 255,300 shares and 8.67 million yuan, and Lexin Technology with 23 instances totaling 137,689 shares and 7.51 million yuan [3] Group 3 - Seven executives from various companies increased their holdings by over 10 million shares, including Wu Mingwu from Shanying International and Zhou Xiaoping from Xingyu Shares [5] - Wu Mingwu increased his holdings by 62,151,200 shares across three transactions, amounting to 109 million yuan [7] - Lin Pusheng from Dazhong Mining increased his holdings by 56,695,300 shares for a total of 194 million yuan [7] Group 4 - ST companies are also actively repurchasing their stocks, including ST Kelly, ST Yifei, ST Saiwei, and *ST Jinshi [9] - ST Kelly's chairman, Yuan Zheng, increased his holdings by 4,365,100 shares, totaling 33.09 million yuan [11] - ST Yifei's executives also participated in repurchases, with Vice President Zhao Laigen and Chairman Wu Xuan increasing their holdings by 75,135 shares and 52,013 shares, respectively [12]

Core Viewpoint - The article highlights the financial struggles of four ST companies listed on the Sci-Tech Innovation Board, all of which experienced significant declines in net profit after their initial public offerings (IPOs) [1] Group 1: Company Overview - As of May 9, there are 586 companies listed on the Sci-Tech Innovation Board, with four classified as ST companies: ST Pava, *ST Guandian, *ST Tianwei, and ST Yifei [1] - All four companies had the highest net profit in the year of their IPO, followed by substantial declines or direct losses in the subsequent year [1] Group 2: ST Pava - ST Pava was listed on September 19, 2022, with a focus on the research, production, and sales of new energy battery materials [2][3] - The company reported revenues of 1.65626 billion yuan in 2022, which dropped to 954.27 million yuan in 2023 and further to 948.57 million yuan in 2024 [3] - The net profit figures were 108.56 million yuan in 2022, -250.03 million yuan in 2023, and -731.76 million yuan in 2024 [3] - The stock was placed under risk warning due to a negative internal control audit opinion from its auditing firm [4] Group 3: *ST Guandian - *ST Guandian transitioned to the Sci-Tech Innovation Board on May 25, 2022, specializing in drone flight services and defense equipment [6] - The company achieved revenues of 291.04 million yuan in 2022, which fell to 212.10 million yuan in 2023 and further declined to 89.98 million yuan in 2024 [7] - The net profit figures were 78.69 million yuan in 2022, 13.26 million yuan in 2023, and -111.15 million yuan in 2024 [7] - The stock was flagged for delisting risk due to negative profit figures and low revenue [8] Group 4: *ST Tianwei - *ST Tianwei was listed on July 30, 2021, focusing on fire suppression systems and related products [9] - The company reported revenues of 205.82 million yuan in 2021, which decreased to 110.75 million yuan in 2022, then increased to 140.48 million yuan in 2023, and dropped to 77.75 million yuan in 2024 [10] - The net profit figures were 114.54 million yuan in 2021, 44.92 million yuan in 2022, 49.70 million yuan in 2023, and -29.16 million yuan in 2024 [10] - The stock was placed under risk warning due to negative profit and revenue figures [11] Group 5: ST Yifei - ST Yifei was listed on July 28, 2023, focusing on precision laser processing equipment [12] - The company achieved revenues of 538.96 million yuan in 2022, 697.2 million yuan in 2023, and 692.1 million yuan in 2024 [13] - The net profit figures were 68.10 million yuan in 2022, 75.75 million yuan in 2023, and 9.41 million yuan in 2024 [13] - The stock was flagged for risk due to negative audit opinions from its auditing firm [13]

民生证券股份有限公司 关于武汉逸飞激光股份有限公司 2024年度持续督导跟踪报告 根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上 市规则》《上海证券交易所上市公司自律监管指引第 11 号——持续督导》等有 关法律法规的规定，民生证券股份有限公司（以下简称"保荐机构"）作为武汉 逸飞激光股份有限公司（以下简称"逸飞激光"或"公司"）首次公开发行股票并 在科创板上市的保荐机构，负责逸飞激光上市后的持续督导工作，并出具本持 续督导跟踪报告，具体情况如下： 一、持续督导工作情况 | | 序号 工作内容 | 持续督导情况 | | --- | --- | --- | | 1 | 建立健全并有效执行持续督导工作制度，并针对具体 | 保荐机构已建立健全并有效执行 | | | 的持续督导工作制定相应的工作计划 | 了持续督导制度，并制定了相应 | | | | 的工作计划 | | 2 | 根据中国证监会相关规定，在持续督导工作开始前， | 保荐机构已与 逸飞激光 签 订 | | | 与上市公司或相关当事人签署持续督导协议，明确双 | 《保荐协议》，该协议明确了双方 | | | 方在持续督导期间的权利义务，并报上 ...